LIMN
Liminatus Pharma, Inc. Class A Common StockNASDAQHealthcare$0.19+6.63%ClosedMarket Cap: $5.0M
As of 2026-04-07
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
-0.45
P/S
0.00
EV/EBITDA
-2.06
DCF Value
$-0.05
FCF Yield
-199.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
201.4%
ROA
-1990.4%
ROIC
35.6%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $0.00 | $-8.5M | $2.18 |
| FY 2025 | $0.00 | $-10.2M | $-0.43 |
| Q3 2025 | $0.00 | $-1.8M | $-0.07 |
| Q2 2025 | $0.00 | $113.3K | $0.00 |
Trading Activity
Insider Trades
View AllIris Acquisition Holdings LLC10 percent owner
SellFri Aug 15
Lemons II Philip Waynedirector:
SellWed Jul 23
Baek Richard JaiHwandirector:
SellMon Jul 21
KH Feelux Co., Ltd10 percent owner
SellFri Jun 27
Valetudo Therapeutics LLC10 percent owner
SellMon Jun 16